Effects of ethanol and ecstasy on conditioned place preference in the rat. 2010

B C Jones, and S Ben-Hamida, and A Pereira de Vasconcelos, and C Kelche, and C Lazarus, and R Jackisch, and J C Cassel
Department of Biobehavioral Health, The Pennsylvania State University, University Park, PA, USA.

The club drug ecstasy (3,4-methylenedioxymethylamphetamine or MDMA) is often taken recreationally with ethanol (EtOH). We have shown previously that EtOH potentiates the psychomotor effects of MDMA in rats. More recently, we demonstrated in striatal slices that MDMA produced preferential release of serotonin, but when combined with EtOH, the preferential release shifted to dopamine, raising the possibility that administration of EtOH may increase the reward effect of MDMA. To address this possibility, adult male Long-Evans rats were tested for conditioned place preference following treatment with saline, EtOH (0.75 g/kg), MDMA (6.6 mg/kg) or the combination. The only condition that produced a preference for the compartment associated with the drug was that of the drug combination. The current data are in line with anecdotal reports and one study in humans, indicating that EtOH alters the pharmacological effects of MDMA including self reports of enhanced or prolonged euphoria. Thus, administration of EtOH might increase the risk for compulsive use of MDMA, an issue that warrants further study.

UI MeSH Term Description Entries
D008297 Male Males
D002492 Central Nervous System Depressants A very loosely defined group of drugs that tend to reduce the activity of the central nervous system. The major groups included here are ethyl alcohol, anesthetics, hypnotics and sedatives, narcotics, and tranquilizing agents (antipsychotics and antianxiety agents). CNS Depressants,Depressants, CNS
D003213 Conditioning, Psychological Simple form of learning involving the formation, strengthening, or weakening of an association between a stimulus and a response. Conditioning, Psychology,Psychological Conditioning,Social Learning Theory,Social Learning Theories,Theory, Social Learning
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D000431 Ethanol A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES. Alcohol, Ethyl,Absolute Alcohol,Grain Alcohol,Alcohol, Absolute,Alcohol, Grain,Ethyl Alcohol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001522 Behavior, Animal The observable response an animal makes to any situation. Autotomy Animal,Animal Behavior,Animal Behaviors
D012201 Reward An object or a situation that can serve to reinforce a response, to satisfy a motive, or to afford pleasure. Rewards
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D018490 Serotonin Agents Drugs used for their effects on serotonergic systems. Among these are drugs that affect serotonin receptors, the life cycle of serotonin, and the survival of serotonergic neurons. Serotonergic Agents,Serotonergic Drugs,Serotonin Drugs,Serotonin Effect,Serotonin Effects,Serotoninergic Effect,Serotoninergic Effects,Agents, Serotonergic,Agents, Serotonin,Drugs, Serotonergic,Drugs, Serotonin,Effect, Serotonin,Effect, Serotoninergic,Effects, Serotonin,Effects, Serotoninergic

Related Publications

B C Jones, and S Ben-Hamida, and A Pereira de Vasconcelos, and C Kelche, and C Lazarus, and R Jackisch, and J C Cassel
September 1998, Psychopharmacology,
B C Jones, and S Ben-Hamida, and A Pereira de Vasconcelos, and C Kelche, and C Lazarus, and R Jackisch, and J C Cassel
January 1990, Pharmacological research,
B C Jones, and S Ben-Hamida, and A Pereira de Vasconcelos, and C Kelche, and C Lazarus, and R Jackisch, and J C Cassel
December 2014, Alcoholism, clinical and experimental research,
B C Jones, and S Ben-Hamida, and A Pereira de Vasconcelos, and C Kelche, and C Lazarus, and R Jackisch, and J C Cassel
September 2006, Progress in neuro-psychopharmacology & biological psychiatry,
B C Jones, and S Ben-Hamida, and A Pereira de Vasconcelos, and C Kelche, and C Lazarus, and R Jackisch, and J C Cassel
September 2017, Psychopharmacology,
B C Jones, and S Ben-Hamida, and A Pereira de Vasconcelos, and C Kelche, and C Lazarus, and R Jackisch, and J C Cassel
May 1996, Behavioural pharmacology,
B C Jones, and S Ben-Hamida, and A Pereira de Vasconcelos, and C Kelche, and C Lazarus, and R Jackisch, and J C Cassel
February 2014, Psychopharmacology,
B C Jones, and S Ben-Hamida, and A Pereira de Vasconcelos, and C Kelche, and C Lazarus, and R Jackisch, and J C Cassel
October 2017, Drug and alcohol dependence,
B C Jones, and S Ben-Hamida, and A Pereira de Vasconcelos, and C Kelche, and C Lazarus, and R Jackisch, and J C Cassel
September 1992, Pharmacology, biochemistry, and behavior,
B C Jones, and S Ben-Hamida, and A Pereira de Vasconcelos, and C Kelche, and C Lazarus, and R Jackisch, and J C Cassel
March 2006, Addiction biology,
Copied contents to your clipboard!